147 related articles for article (PubMed ID: 37834388)
1. p53 in the Molecular Circuitry of Bone Marrow Failure Syndromes.
Rakotopare J; Toledo F
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834388
[TBL] [Abstract][Full Text] [Related]
2. Telomere length in inherited bone marrow failure syndromes.
Alter BP; Giri N; Savage SA; Rosenberg PS
Haematologica; 2015 Jan; 100(1):49-54. PubMed ID: 25304614
[TBL] [Abstract][Full Text] [Related]
3. Analysis of telomeres in peripheral blood cells from patients with bone marrow failure.
Pavesi E; Avondo F; Aspesi A; Quarello P; Rocci A; Vimercati C; Pigullo S; Dufour C; Ramenghi U; Dianzani I
Pediatr Blood Cancer; 2009 Sep; 53(3):411-6. PubMed ID: 19489057
[TBL] [Abstract][Full Text] [Related]
4. A systematic approach identifies p53-DREAM pathway target genes associated with blood or brain abnormalities.
Rakotopare J; Lejour V; Duval C; Eldawra E; Escoffier H; Toledo F
Dis Model Mech; 2023 Oct; 16(10):. PubMed ID: 37661832
[TBL] [Abstract][Full Text] [Related]
5. Inherited bone marrow failure syndromes: molecular features.
Shimamura A
Hematology Am Soc Hematol Educ Program; 2006; ():63-71. PubMed ID: 17124042
[TBL] [Abstract][Full Text] [Related]
6. Genomic characterization of the inherited bone marrow failure syndromes.
Khincha PP; Savage SA
Semin Hematol; 2013 Oct; 50(4):333-47. PubMed ID: 24246701
[TBL] [Abstract][Full Text] [Related]
7. p53 pathway activation by telomere attrition in X-DC primary fibroblasts occurs in the absence of ribosome biogenesis failure and as a consequence of DNA damage.
Carrillo J; González A; Manguán-García C; Pintado-Berninches L; Perona R
Clin Transl Oncol; 2014 Jun; 16(6):529-38. PubMed ID: 24065372
[TBL] [Abstract][Full Text] [Related]
8. De Novo Mutations Activating Germline TP53 in an Inherited Bone-Marrow-Failure Syndrome.
Toki T; Yoshida K; Wang R; Nakamura S; Maekawa T; Goi K; Katoh MC; Mizuno S; Sugiyama F; Kanezaki R; Uechi T; Nakajima Y; Sato Y; Okuno Y; Sato-Otsubo A; Shiozawa Y; Kataoka K; Shiraishi Y; Sanada M; Chiba K; Tanaka H; Terui K; Sato T; Kamio T; Sakaguchi H; Ohga S; Kuramitsu M; Hamaguchi I; Ohara A; Kanno H; Miyano S; Kojima S; Ishiguro A; Sugita K; Kenmochi N; Takahashi S; Eto K; Ogawa S; Ito E
Am J Hum Genet; 2018 Sep; 103(3):440-447. PubMed ID: 30146126
[TBL] [Abstract][Full Text] [Related]
9. [Bone marrow failure and TP53 activating mutations].
Ito E
Rinsho Ketsueki; 2022; 63(9):1115-1125. PubMed ID: 36198537
[TBL] [Abstract][Full Text] [Related]
10. [Anemia in children].
Muramatsu H; Kojima S
Nihon Rinsho; 2008 Mar; 66(3):544-7. PubMed ID: 18326324
[TBL] [Abstract][Full Text] [Related]
11. p53 Mediates Failure of Human Definitive Hematopoiesis in Dyskeratosis Congenita.
Fok WC; Niero ELO; Dege C; Brenner KA; Sturgeon CM; Batista LFZ
Stem Cell Reports; 2017 Aug; 9(2):409-418. PubMed ID: 28757166
[TBL] [Abstract][Full Text] [Related]
12. Germline mutation of
Toufektchan E; Lejour V; Durand R; Giri N; Draskovic I; Bardot B; Laplante P; Jaber S; Alter BP; Londono-Vallejo JA; Savage SA; Toledo F
Sci Adv; 2020 Apr; 6(15):eaay3511. PubMed ID: 32300648
[TBL] [Abstract][Full Text] [Related]
13. p53 downregulates the Fanconi anaemia DNA repair pathway.
Jaber S; Toufektchan E; Lejour V; Bardot B; Toledo F
Nat Commun; 2016 Apr; 7():11091. PubMed ID: 27033104
[TBL] [Abstract][Full Text] [Related]
14. Fanconi's anaemia and related bone marrow failure syndromes.
Dokal I
Br Med Bull; 2006; 77-78():37-53. PubMed ID: 16968690
[TBL] [Abstract][Full Text] [Related]
15. The genomics of inherited bone marrow failure: from mechanism to the clinic.
Wegman-Ostrosky T; Savage SA
Br J Haematol; 2017 May; 177(4):526-542. PubMed ID: 28211564
[TBL] [Abstract][Full Text] [Related]
16. Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients.
Gu BW; Apicella M; Mills J; Fan JM; Reeves DA; French D; Podsakoff GM; Bessler M; Mason PJ
PLoS One; 2015; 10(5):e0127414. PubMed ID: 25992652
[TBL] [Abstract][Full Text] [Related]
17. Telomere length in blood, buccal cells, and fibroblasts from patients with inherited bone marrow failure syndromes.
Gadalla SM; Cawthon R; Giri N; Alter BP; Savage SA
Aging (Albany NY); 2010 Nov; 2(11):867-74. PubMed ID: 21113082
[TBL] [Abstract][Full Text] [Related]
18. Ribosomal dysfunction and inherited marrow failure.
Ganapathi KA; Shimamura A
Br J Haematol; 2008 May; 141(3):376-87. PubMed ID: 18410571
[TBL] [Abstract][Full Text] [Related]
19. Inherited bone marrow failure syndromes in adolescents and young adults.
Wilson DB; Link DC; Mason PJ; Bessler M
Ann Med; 2014 Sep; 46(6):353-63. PubMed ID: 24888387
[TBL] [Abstract][Full Text] [Related]
20. Dyskeratosis congenita: a disorder of defective telomere maintenance?
Walne AJ; Marrone A; Dokal I
Int J Hematol; 2005 Oct; 82(3):184-9. PubMed ID: 16207588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
